Conductive composite electrode material

• US 7,899,552 B2
• Filed: 09/24/2008
• Issued: 03/01/2011
• Est. Priority Date: 10/15/2007
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Eidenschink, Tracee E. J., Atanasoska, L. Liliana, Shippy, J. Lee III, Chandrasekaran, Chandru
• Primary Examiner(s): Layno; Carl H
• Assistant Examiner(s): Gedeon; Brian T
• Application Number:
  US12/237,099
• Publication Number:
  US 20090099634A1
• Time in Patent Office: 888 Days
• Field of Search: 607115-121
• US Class Current: 607/122
• CPC Class Codes: A61N 1/05 for implantation or insertion into the body, e.g. heart electrode A61N1/06 takes precedence
• CPC Class Codes: A61N 1/0565 Electrode heads
• CPC Class Codes: A61N 1/0568 with drug delivery

Abstract

A medical electrical lead and body implantable electrode suitable for a variety of medical applications are disclosed. In general, the electrode includes a composite material having particles of pseudo-capacitive material, such as iridium oxide, dispersed within a polymer matrix including a polyelectrolyte. The polymer matrix can also include a conductive polymer doped with an excess of the polyelectrolyte. The composite may used to form the electrode itself or an electrode coating. The presence of a pseudo-capacitive material within the composite may increase the charge-storage capacity of the electrode and may allow for safe deliveries of charge densities within an electrochemical window suitable for pacing a patient'"'"'s heart.

Claims

1. A medical electrical lead comprising:

a lead body including a conductor extending from a proximal end adapted to be connected to a pulse generator to a distal end; and

at least one electrode operatively connected to the conductor, the electrode comprising a polymer matrix including a conductive polymer doped with an excess of a negatively charged polyelectrolyte and pseudo-capacitive, transition metal oxide particles dispersed throughout the polymer matrix.

2. The medical electrical lead of claim 1, wherein the electrode includes a conductive base material operatively connected to the conductor and wherein a coating including the polymer matrix is coated over at least a portion of the base material.

3. The medical electrical lead of claim 1, wherein the conductive polymer is selected from the group consisting of polypyrrole, polyaniline, polyacetylene, polythiophene, polyethylenedioxythiophene, poly (p-phenyl vinylene), and mixtures thereof.

4. The medical electrical lead of claim 1, wherein the conductive polymer comprises polyethylenedioxythiophene.

5. The medical electrical lead of claim 1, wherein the negatively charged polyelectrolyte is selected from the group consisting of polystyrene sulfonate, polyglutamic acid, Nafion, and mixtures thereof.

6. The medical electrical lead of claim 1, wherein the negatively charged polyelectrolyte comprises polystyrene sulfonate.

7. The medical electrical lead of claim 1, wherein the pseudo-capacitive, transition metal oxide particles are selected from the group consisting of iridium oxide particles, ruthenium oxide particles, rhodium oxide particles, osmium oxide particles, titanium oxide particles, and combinations thereof.

8. The medical electrical lead of claim 1, wherein the pseudo-capacitive, transition metal oxide particles comprise iridium oxide particles.

9. The medical electrical lead of claim 1 wherein the pseudo-capacitive material is present in a sufficient amount such that an electrode potential of the electrode is maintained within an electrochemical window suitable for pacing a heart.

10. The medical electrical lead of claim 1, wherein the conductive polymer comprises polyethylenedioxythiophene, the negatively charged electrolyte comprises polystyrene sulfonate, and the pseudo capacitive material comprises iridium oxide particles.

11. The medical electrical lead of claim 1, wherein the conductive polymer comprises polypyrrole and the negatively charged electrolyte comprises polyglutamic acid.

12. A medical electrical lead comprising

a lead body including a conductor extending from a proximal end adapted to be connected to a pulse generator to a distal end;

and

an electrode comprising a conductive base material and a coating comprising a conductive composite material disposed on at least a portion of the base material, the composite material comprising a polymer matrix comprising a conductive polymer doped with an excess of a negatively charged polyelectrolyte and pseudo-capacitive, transition metal oxide particles dispersed throughout the polymer matrix.

13. The medical electrical lead according to claim 12, wherein the conductive polymer is selected from the group consisting of polypyrrole, polyaniline, polyacetylene, polythiophene, polyethylenedioxythiophene, poly(p-phenyl vinylene), and mixtures thereof.

14. The medical electrical lead of claim 12, wherein the conductive polymer comprises polyethylenedioxythiophene and the negatively charged electrolyte comprises polystyrene sulfonate.

15. The medical electrical lead of claim 12, wherein the negatively charged polyelectrolyte is selected from the group consisting of polystyrene sulfonate, polyglutamic acid, Nafion, and mixtures thereof.

16. The medical electrical lead of claim 12, wherein the negatively charged polyelectrolyte is polystyrene sulfonate.

17. The medical electrical lead of claim 12, wherein the pseudo-capacitive, transition metal oxide particles are selected from the group consisting of iridium oxide particles, ruthenium oxide particles, rhodium oxide particles, titanium oxide particles, osmium oxide particles, and combinations thereof.

18. The medical electrical lead of claim 12, wherein the pseudo-capacitive, transition metal oxide particles comprise iridium oxide particles.

19. The medical electrical lead of claim 12, wherein the conductive polymer comprises polypyrrole and the negatively charged electrolyte comprises polyglutamic acid.

20. A body implantable electrode comprising:

a conductive metal base;

a composite coating disposed over at least a portion of the conductive base, composite coating including a polymer matrix comprising a conductive polymer doped with an excess of a negatively-charged polyelectrolyte and pseudo-capacitive, transition metal oxide particles dispersed throughout the polymer matrix.

21. The body implantable electrode of claim 20, wherein the conductive metal base includes a first layer comprising a pseudo-capacitive material and a second layer comprising the composite coating.

22. The body implantable electrode of claim 20, wherein the polymer matrix comprises polyethylenedioxythiophene doped with an excess of polystyrene sulfonate and the pseudo capacitive material comprises iridium oxide particles.

23. The body implantable electrode of claim 20, wherein the polymer matrix comprises polypyrrole doped with an excess of polyglutamic acid.